Current Management of Basal Cell Carcinoma

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

Zugriff auf Dokument

@article{2065353668004314bf1da36bab38579c,

title = "Current Management of Basal Cell Carcinoma",

keywords = "SKIN-CANCER, PHOTODYNAMIC THERAPY, DOUBLE-BLIND, VISMODEGIB, CONSENSUS, RISK, DIAGNOSIS, IMIQUIMOD, TRIAL",

author = "Manuel Krieter and Erwin Schultz",

note = "beide: Paracelsus Med Privatuniv Nurnberg, Univ Klin Dermatol, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany",

year = "2022",

doi = "10.1055/a-1487-3853",

language = "Deutsch",

journal = "Aktuelle Dermatologie",

issn = "0340-2541",

}

TY - JOUR

T1 - Current Management of Basal Cell Carcinoma

AU - Krieter, Manuel

AU - Schultz, Erwin

N1 - beide: Paracelsus Med Privatuniv Nurnberg, Univ Klin Dermatol, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany

PY - 2022

Y1 - 2022

KW - SKIN-CANCER

KW - PHOTODYNAMIC THERAPY

KW - DOUBLE-BLIND

KW - VISMODEGIB

KW - CONSENSUS

KW - RISK

KW - DIAGNOSIS

KW - IMIQUIMOD

KW - TRIAL

U2 - 10.1055/a-1487-3853

DO - 10.1055/a-1487-3853

M3 - Originalarbeit

SN - 0340-2541

JO - Aktuelle Dermatologie

JF - Aktuelle Dermatologie

ER -